1. The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective.
- Author
-
Elmonem MA, Belanger-Quintana A, Bordugo A, Boruah R, Cortès-Saladelafont E, Endrakanti M, Giraldo P, Grünert SC, Gupta N, Kabra M, Knerr I, Krämer J, Kuster A, Levtchenko E, Ngu LH, Rovira-Remisa MM, Sass JO, Sykut-Cegielska J, Tummolo A, and van den Heuvel LP
- Subjects
- Africa epidemiology, Asia epidemiology, COVID-19 epidemiology, COVID-19 virology, Comorbidity, Delivery of Health Care methods, Delivery of Health Care trends, Europe epidemiology, Humans, Infant, Newborn, Mass Screening methods, Mass Screening statistics & numerical data, Metabolism, Inborn Errors epidemiology, Neonatal Screening methods, Pandemics, Phenylketonurias diagnosis, Phenylketonurias epidemiology, Phenylketonurias therapy, SARS-CoV-2 physiology, COVID-19 prevention & control, Delivery of Health Care statistics & numerical data, Metabolism, Inborn Errors diagnosis, Metabolism, Inborn Errors therapy
- Abstract
Quantitative estimates for the global impact of COVID-19 on the diagnosis and management of patients with inborn errors of metabolism (IEM) are lacking. We collected relevant data from 16 specialized medical centers treating IEM patients in Europe, Asia and Africa. The median decline of reported IEM related services in March 1st-May 31st 2020 compared to the same period in 2019 were as high as 60-80% with a profound impact on patient management and care for this vulnerable patient group. More representative data along with outcome data and guidelines for managing IEM disorders under such extraordinary circumstances are needed., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest regarding the current study., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF